SS2 (Docusate sodium and senna docusate sodium 50 mg / sennosides 8.6 mg)
Pill imprint SS2 has been identified as Docusate sodium and senna docusate sodium 50 mg / sennosides 8.6 mg.
Docusate/senna is used in the treatment of constipation, acute and belongs to the drug class laxatives. FDA has not classified the drug for risk during pregnancy. Docusate/senna docusate sodium 50 mg / sennosides 8.6 mg is classified as a Schedule N controlled substance under the Controlled Substance Act (CSA).
More about docusate/senna
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2015 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.